Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zaniboni

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Current Gerontology and Geriatrics Research|July 31, 2010
Epidermal growth factor receptor tyrosine kinase inhibitors for elderly patients with advanced non-small cell lung cancerF Meriggi, A Zaniboni
Cancer Chemotherapy and Pharmacology|April 20, 2016
The Best. First. Anti-EGFR before anti-VEGF, in the first-line treatment of RAS wild-type metastatic colorectal cancer: from bench to bedsideA Zaniboni, V Formica
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
The Renaissance of platinum-based chemotherapy for metastatic breast cancerF Meriggi, B Di Biasi, A Zaniboni
The Journal of Infusional Chemotherapy|January 1, 1995
5-fluorouracil by protracted subcutaneous infusion. A pilot studyA Zaniboni, F Meriggi, A Alghisi, et al.
Medical Hypotheses|June 17, 2020
Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with <sup>18</sup>F-Fluorocholine PET/CT?G Savelli, M Bonacina, A Rizzo, et al.
British Journal of Cancer|March 1, 1988
Phase II study of 5-fluorouracil (5-FU) and high dose folinic acid (HDFA) in hepatocellular carcinomaA Zaniboni, E Simoncini, P Marpicati, et al.
Chemotherapy|December 8, 2007
The potential role of pemetrexed in gastrointestinal cancerF Meriggi, B Di Biasi, C Caliolo, et al.
Reviews on Recent Clinical Trials|December 24, 2009
The use of bevacizumab and trastuzumab beyond tumor progression: a new avenue in cancer treatment?F Meriggi, C Abeni, B Di Biasi, et al.
Current Drug Targets|August 12, 2009
Anti-EGFR therapy in colorectal cancer: how to choose the right patientF Meriggi, B Di Biasi, C Abeni, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 21, 2007
Visual and computer-based detection of slow eye movements in overnight and 24-h EOG recordingsE Magosso, M Ursino, A Zaniboni, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Current Gerontology and Geriatrics Research|July 31, 2010
Epidermal growth factor receptor tyrosine kinase inhibitors for elderly patients with advanced non-small cell lung cancerF Meriggi, A Zaniboni
Cancer Chemotherapy and Pharmacology|April 20, 2016
The Best. First. Anti-EGFR before anti-VEGF, in the first-line treatment of RAS wild-type metastatic colorectal cancer: from bench to bedsideA Zaniboni, V Formica
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
The Renaissance of platinum-based chemotherapy for metastatic breast cancerF Meriggi, B Di Biasi, A Zaniboni
The Journal of Infusional Chemotherapy|January 1, 1995
5-fluorouracil by protracted subcutaneous infusion. A pilot studyA Zaniboni, F Meriggi, A Alghisi, et al.
Medical Hypotheses|June 17, 2020
Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with <sup>18</sup>F-Fluorocholine PET/CT?G Savelli, M Bonacina, A Rizzo, et al.
British Journal of Cancer|March 1, 1988
Phase II study of 5-fluorouracil (5-FU) and high dose folinic acid (HDFA) in hepatocellular carcinomaA Zaniboni, E Simoncini, P Marpicati, et al.
Chemotherapy|December 8, 2007
The potential role of pemetrexed in gastrointestinal cancerF Meriggi, B Di Biasi, C Caliolo, et al.
Reviews on Recent Clinical Trials|December 24, 2009
The use of bevacizumab and trastuzumab beyond tumor progression: a new avenue in cancer treatment?F Meriggi, C Abeni, B Di Biasi, et al.
Current Drug Targets|August 12, 2009
Anti-EGFR therapy in colorectal cancer: how to choose the right patientF Meriggi, B Di Biasi, C Abeni, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 21, 2007
Visual and computer-based detection of slow eye movements in overnight and 24-h EOG recordingsE Magosso, M Ursino, A Zaniboni, et al.
Pageof 11